Edition:
United States

Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

47.84USD
2:38pm EST
Change (% chg)

$0.34 (+0.72%)
Prev Close
$47.50
Open
$47.45
Day's High
$47.84
Day's Low
$46.65
Volume
16,265
Avg. Vol
41,336
52-wk High
$54.90
52-wk Low
$35.07

ANIK.OQ

Chart for ANIK.OQ

About

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company offers therapeutic pain management solutions. It is engaged in developing, manufacturing and commercializing approximately 20 products based on its hyaluronic acid (HA) technology. It orthopedic medicine portfolio consists of marketed (ORTHOVISC and... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $694.60
Shares Outstanding(Mil.): 14.62
Dividend: --
Yield (%): --

Financials

  ANIK.OQ Industry Sector
P/E (TTM): 20.35 30.14 30.77
EPS (TTM): 2.33 -- --
ROI: 16.40 15.85 15.23
ROE: 17.14 16.96 16.56

BRIEF-Anika Q3 earnings per share $0.59

* Q3 earnings per share view $0.47 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Oct 26 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $110.51 -1.55
Novartis AG (NOVN.S) CHF68.75 -0.65
Pfizer Inc. (PFE.N) $31.01 -0.55
Roche Holding Ltd. (ROG.S) CHF221.20 -2.30
Roche Holding Ltd. (RO.S) CHF225.20 -3.00
Merck & Co., Inc. (MRK.N) $59.83 -0.45
Bayer AG (BAYGn.DE) €90.10 +1.94
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.10 -0.45
Abbott Laboratories (ABT.N) $38.29 -0.13

Earnings vs. Estimates